Management of chronic myeloid leukemia in myeloid blastic phase with novel therapies: a systematic literature review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of chronic myeloid leukemia in myeloid blastic phase with novel therapies: a systematic literature review

Published:2022-05-04 Issue:5 Volume:15 Page:423-429
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Yılmaz Umut¹,Bulan Batuhan²,Belli Çağrı³,Eşkazan Ahmet Emre¹^ORCID

Affiliation:

1. Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey

2. Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey

3. Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2022.2076669

Reference23 articles.

1. Blast and accelerated phase CML: room for improvement

2. Management of CML-blast crisis

3. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

4. Management of Chronic Myeloid Leukemia in Advanced Phase

5. New drugs approved for acute myeloid leukaemia in 2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report;Clinical Case Reports;2023-01

2. Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase;Frontiers in Immunology;2022-11-29

3. Developing therapeutic approaches for chronic myeloid leukemia: a review;Molecular and Cellular Biochemistry;2022-10-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3